Real-time identification of liver cancers by using indocyanine green fluorescent imaging

Cancer

Volumn 115, Issue 11, 2009, Pages 2491-2504

  Ishizawa, Takeaki ^a   Fukushima, Noriyoshi ^a   Shibahara, Junji ^a   Masuda, Koichi ^a   Tamura, Sumihito ^a   Aoki, Taku ^a   Hasegawa, Kiyoshi ^a   Beck, Yoshifumi ^a   Fukayama, Masashi ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diagnosis; Early hepatocellular carcinoma; Hepatocellular carcinoma; Liver metastasis; Liver resection

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DRUG UPTAKE; FALSE POSITIVE RESULT; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER RESECTION; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; COLORING AGENTS; COMPUTER SYSTEMS; DIAGNOSTIC IMAGING; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; LIVER NEOPLASMS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED;

EID: 66649121434     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24291     Document Type: Article

References (31)

1. Sahani DV, Kalva SP, Tanabe KK, et al. Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology. 2004;232:810-814. (Pubitemid 39100267)
2. Zhang K, Kokudo N, Hasegawa K, et al. Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma. Arch Surg. 2007;142:1170-1175. (Pubitemid 350294269)
3. Machi J, Isomoto H, Kurohiji T, et al. Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: evaluation with postoperative follow-up results. World J Surg. 1991;15:551-556.
4. Leen E, Ceccotti P, Moug SJ, et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg. 2006;243:236-240.
5. Nomura K, Kadoya M, Ueda K, Fujinaga Y, Miwa S, Miyagawa S. Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging. J Clin Gastroenterol. 2007;41:789-795. (Pubitemid 47267767)
6. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer. 1987;60:810-819.
7. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998;28:1241-1246. (Pubitemid 28493833)
8. Liver Cancer Study Group of Japan. Classification of primary liver cancer. 4th ed. Tokyo: Kanehara; 2001.
9. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005;25:133-142. (Pubitemid 40781066)
10. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917. (Pubitemid 37518510)
11. Rubens FD, Ruel M, Fremes SE. A new and simplified method for coronary and graft imaging during CABG. Heart Surg Forum. 2002;5:141-144. (Pubitemid 34790208)
12. Balacumaraswami L, Abu-Omar Y, Choudhary B, Pigott D, Taggart DP. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J Thorac Cardiovasc Surg. 2005;130:315-320. (Pubitemid 41074159)
13. Landsman ML, Kwant G, Mook GA, Zijlstra WG. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol. 1976;40:575-583.
14. Ishizawa T, Tamura S, Masuda K, et al. Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg. 2009;208:e1-e4.
15. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960;39:592-600.
16. Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908-1916.
17. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985;161:346-350. (Pubitemid 16223044)
18. Kokudo N, Bandai Y, Imanishi H, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Surgery. 1996;119:634-640. (Pubitemid 26182451)
19. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298-304. (Pubitemid 23216368)
20. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
21. Ni Y, Marchal G, Yu J, et al. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. Radiology. 1993;188:45-51. (Pubitemid 23183097)
22. Coffin CM, Diche T, Mahfouz A, Alexandre M, Caseiro-Alves F, Rahmouni A. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol. 1999;9:444-449.
23. Wang DB, Zhou KR, Zeng MS, Chen KM, Wang YX. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology. Eur Radiol. 2004;14:743-745. (Pubitemid 38444592)
24. Chung JJ, Kim MJ, Kim KW. Mangafodipir trisodiume-nhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? J Magn Reson Imaging. 2006;23:706-711.
25. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2004;22:93-97. (Pubitemid 38057962)
26. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990;336:1150-1153. (Pubitemid 20362906)
27. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology. 1998;115:1216-1222. (Pubitemid 28485613)
28. Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology. 2005;42:809-818. (Pubitemid 41401118)
29. Llovet JM, Chen Y, Wurmbach E, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 2006;131:1758-1767. (Pubitemid 46001394)
30. Gagner M, Rheault M, Dubuc J. Laparoscopic partial hepatectomy for liver tumor. Surg Endosc. 1992;6:97-98.
31. Belli G, Fantini C, D'Agostino A, et al. Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results. Surg Endosc. 2007;21:2004-2011. (Pubitemid 47620293)